• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.18%

    Celgene Corporation (CELG)

    -NasdaqGS
    107.02 Down 0.93(0.86%) 4:00PM EDT
    |After Hours : 107.19 Up 0.17 (0.16%) 7:59PM EDT
    Prev Close:107.95
    Open:107.89
    Bid:106.81 x 200
    Ask:107.20 x 200
    1y Target Est:137.39
    Beta:1.4589
    Earnings Date:Nov 3 - Nov 7 (Est.)
    Day's Range:106.74 - 108.51
    52wk Range:93.05 - 128.39
    Volume:3,196,596
    Avg Vol (3m):4,514,190
    Market Cap:82.95B
    P/E (ttm):45.23
    EPS (ttm):2.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CELGDown 0.86%82.95B
    JNJDown 0.38%326.86B

    Key Statistics

    Forward P/E (1 yr):15.31
    P/S (ttm):8.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :5.70
    Quarterly EPS Est (Sep-16) :1.48
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):0.87

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell ly... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback